The introduction of buprenorphine‐naloxone film in opioid substitution therapy in Australia: Uptake and issues arising from changing buprenorphine formulations

Publisher： John Wiley & Sons Inc

E-ISSN： 1465-3362|34|6|603-610

ISSN： 0959-5236

Source： DRUG AND ALCOHOL REVIEW, Vol.34, Iss.6, 2015-11, pp. : 603-610

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Injecting buprenorphine‐naloxone film: Findings from an explorative qualitative study

By  

DRUG AND ALCOHOL REVIEW, Vol. 34, Iss. 6, 2015-11 ,pp. : 623-629

John Wiley & Sons Inc

Access to resources Recommend Favorite

Suboxone® (Buprenorphine/Naloxone) as an Agonist Opioid Treatment in Spain: A Budgetary Impact Analysis

By  

European Addiction Research, Vol. 16, Iss. 1, 2009-11 ,pp. : 31-42

Karger

Access to resources Recommend Favorite

Comparison of Buprenorphine and Methadone in the Treatment of Opioid Dependence

By  

European Addiction Research, Vol. 4, Iss. 1, 1998-10 ,pp. : 13-18

Karger

Access to resources Recommend Favorite

Substitution with Buprenorphine in Methadone- and Morphine Sulfate-Dependent Patients

By  

European Addiction Research, Vol. 4, Iss. 1, 1998-10 ,pp. : 8-12

Karger

Access to resources Recommend Favorite

Differences between General Practitioner- and Addiction Centre-Prescribed Buprenorphine Substitution Therapy in France

By  

European Addiction Research, Vol. 4, Iss. 1, 1998-10 ,pp. : 24-28

Karger

Access to resources Recommend Favorite